These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2735232)

  • 1. [Clinical studies on urinary tissue polypeptide antigen (TPA): problems and improvement in determination].
    Yoshida M; Morimoto S; Uekado Y; Yasukawa S; Aoshi H; Yoshida T; Ebisuno S; Ohkawa T
    Hinyokika Kiyo; 1989 Feb; 35(2):217-23. PubMed ID: 2735232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers].
    Ohmori H; Ohashi T; Aso Y; Kumamoto Y; Hisazumi H; Shiraiwa Y; Kurita T; Shimazaki J; Ohkawa T; Ogawa H
    Hinyokika Kiyo; 1988 Dec; 34(12):2101-10. PubMed ID: 3071123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
    Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H
    Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.
    Ecke TH; Lenk SV; Schlechte HH; Loening SA
    Anticancer Res; 2003; 23(2A):957-62. PubMed ID: 12820330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the measurement of urinary TPA].
    Torizumi K; Yamada R; Ebisuno S; Fujinaga T
    Radioisotopes; 1984 Mar; 33(3):150-3. PubMed ID: 6473832
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fundamental and clinical evaluation of a tissue polypeptide antigen (TPA) kit--TPA as a tumor marker].
    Masaka M; Yoshimi T
    Radioisotopes; 1983 Dec; 32(12):633-6. PubMed ID: 6676781
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of TPA-assay kit using monoclonal antibodies].
    Saga T; Sakahara H; Kousaka T; Yao Z; Nakamoto Y; Hattori N; Zhang M; Nakayama M; Ohshio G; Imamura M; Konishi J
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):615-21. PubMed ID: 8678521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.
    Ecke TH; Schlechte HH; Schulze G; Lenk SV; Loening SA
    Anticancer Res; 2005; 25(1B):635-41. PubMed ID: 15816639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tissue polypeptide antigen (TPA) in urological malignancies. I. S-TPA in bladder cancer patients].
    Akiyama T; Tsujihashi H; Boku E; Nagai N; Matsuura T; Iguchi M; Yachiku S; Kurita T
    Hinyokika Kiyo; 1983 Dec; 29(12):1635-40. PubMed ID: 6677110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tissue polypeptide antigen (TPA) as tumor marker for bladder cancer.
    van Poppel H; Billen J; Goethuys H; Elgamal AA; Gerits M; Mortelmans L; Blanckaert N; Baert L
    Anticancer Res; 1996; 16(4B):2205-7. PubMed ID: 8694544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
    Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental studies of measurement of serum tissue polypeptide antigen (TPA) using TPA RIA kit Prolifigen].
    Endo K; Sakahara H; Nakajima K; Nakajima T; Ohta H; Torizuka K
    Kaku Igaku; 1984 Jan; 21(1):75-81. PubMed ID: 6737794
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer].
    Fukunaga M; Otsuka N; Yanagi M; Sone T; Muranaka A; Yanagimoto S; Tomomitsu T; Morita R; Ohama T; Sonoo H
    Gan No Rinsho; 1985 Jul; 31(8):923-8. PubMed ID: 4032770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies on the measurement of serum tissue polypeptide antigen (TPA) concentrations using prolifigen TPA radioimmunoassay kit "Daiichi"].
    Torizuka K
    Kaku Igaku; 1985 Sep; 22(9):1419-29. PubMed ID: 4087562
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR; Zhang X; Xu ZF; Zheng S
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
    Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Matsushima M; Kuwabara T; Miyamae K; Hachiya A; Kawahara M; Fukasawa K; Yagishita T; Tajima M; Sawamura Y; Shirai M
    Hinyokika Kiyo; 1984 Jul; 30(7):869-75. PubMed ID: 6507205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of urinary CEA, ferritin and TPA in Egyptian bladder cancer patients.
    Halim AB; el-Ahmady O; Hamza S; Aboul-Ela M; Oehr P
    Int J Biol Markers; 1992; 7(4):234-9. PubMed ID: 1491179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of serum tissue polypeptide antigen (TPA) concentrations in patients with malignancy of the digestive system using TPA RIA kit Prolifigen].
    Sakahara H; Endo K; Nakajima K; Nakashima T; Ohta H; Torizuka K; Fukuda Y
    Kaku Igaku; 1984 Jan; 21(1):83-9. PubMed ID: 6737795
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of cytokeratin markers TPA, TPA (cyk), TPS and CYFRA 21.1 in metastatic disease.
    van Dalen A
    Anticancer Res; 1996; 16(4B):2345-9. PubMed ID: 8694567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.